• Skip to navigation
  • Skip to content
Close search
  • Log In
  • Store
  • Contact
  • Job Board
Menu
LeadingAge Minnesota
  • About
    • About Us
    • About LeadingAge Minnesota
    • Our Team
    • Our Board
    • Committees
    • District Meetings
    • Directories
    • About Our Partners
    • LeadingAge Minnesota Foundation
    • LeadingAge Minnesota Solutions
    • Value First
    • LeadingAge
    • Argentum
    • Caring Careers Start Here
  • Join
    • For Provider Members
    • For Business Partners and Sponsors
  • Resources
    • Find Resources
    • Resource Library
    • Member Directory
    • Business Partner Directory
    • Group Purchasing Discounts
    • Expert Support
    • Learn More
    • Workforce
    • Assisted Living Licensure
    • Quality, Excellence, and Safety
    • Board Resources
    • Nursing Home Workforce Standards Board
    • Deregulation
  • Education & Events
    • Learn
    • CEUs
    • On-Demand Learning
    • Licensed Assisted Living Director Training
    • Executive Leadership Masterclass
    • Nurse Leadership Program
    • Leadership Academy
    • Billing Basics and More
    • Quality Specialist Certificate Program
    • Operations Certificate Program
    • Attend
    • Calendar of Events
    • Annual Meeting & Leadership Forum
    • 2026 Institute & Expo
    • Assisted Living Conference
    • Technology Conference
    • Event FAQs
  • News
    • Read Advantage
    • Press Room
  • Get Involved
    • Advocate
    • Policy Priorities
    • Take Action!
    • Political Action Committee
    • Connect
    • Huddle
    • Coaching Room
    • Committees
    • District Meetings
    • Professional Networks
Open search

News

News related to "psychotropic"

Choose an article below to learn more about this topic.

CMS to Increase Scrutiny of Psychotropic Drug Use

On December 22, 2022 by LeadingAge

The Office of the Inspector General (OIG) released a report outlining the potentially inappropriate use of several psychotropic medications, including antipsychotics, anxiolytics, sedative-hypnotics, and anticonvulsants. As a result, the Centers for Medicare and Medicaid Services (CMS) plans to increase its oversight of psychotropic drugs and focus more closely on certain drug classes.

News Categories

  • Featured News
  • State News
  • Federal News
  • Notable News
  • Member News
  • LeadingAge Minnesota Education Solutions
  • Other Meetings and Events
  • Monday Member Message
  • All news »

News Related to

assisted living, workforce, covid-19, education, nursing home, ceus, adult day, advocacy, quality, mdh

Connect

  • Connect with other members »
  • Membership directory »
  • Want to talk? Contact us »
  • Find a job/Post a job »
LeadingAge Minnesota
  • Become a Member
  • Become a Sponsor
  • Privacy Policy
  • Press Room

3001 Broadway Street NE, Suite 300, Minneapolis, MN 55413

(651) 645-4545 / (800) 462-5368

©2025 LeadingAge Minnesota